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controlled trial
Cato A Basson1*, Aimee Stewart2 and Witness Mudzi2Abstract
Background: Neck pain is a common musculoskeletal complaint and is often associated with shoulder or arm pain.
There is a paucity of information on effective treatment for neck and arm pain, such as radiculopathy or cervico-brachial
pain. Guidelines recommend neck mobilisation/ manipulation, exercises and advice as the treatment for neck pain, and
neck and arm pain. There are a few studies that have used neural mobilisation as the treatment for cervico-brachial pain.
Although results seem promising the studies have small sample sizes that make it difficult to draw definite conclusions.
Methods: A randomised controlled trial will be used to establish the effect of neural mobilisation on the pain, function
and quality of life of patients with cervico-brachial pain. Patients will be recruited in four physiotherapy private practices
and randomly assigned to usual care or usual care plus neural mobilisation.
Discussion: In clinical practice neural mobilisations is commonly used for cervico-brachial pain. Although study
outcomes seem promising, most studies have small participant numbers. Targeting the neural structures as part of the
management plan for a subgroup of patients with nerve mechano-sensitivity seems feasible. Patients with neuropathic
pain and psychosocial risk factors such as catastrophising, respond poorly to treatment. Although a recent study found
these patients less likely to respond to neural mobilisation, the current study will be able to assess whether neural
mobilisation has any added benefit compared to usual care. The study will contribute to the knowledge base of
treatment of patients with cervico-brachial pain. The findings of the study will be published in an appropriate journal.
Trial registration: Trial registration Number: PACTR201303000500157.
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Neck pain is one of the most common debilitating mus-
culoskeletal complaints seen in physiotherapy practice
[1-3]. In a systematic review on the prevalence of neck
pain in the adult population, Fejer et al. found the point
prevalence to be 7.6% and the lifetime prevalence to be
48.6% [4]. In the 2010 global burden of disease report
neck pain ranked as the fourth highest disease in terms
of disability [5].
Neck pain is often associated with headache, upper
back and shoulder/arm pain [3,6]. In a study by Daffner
et al. [7] 65.4% of the neck pain population included in* Correspondence: annalieb@intekom.co.za
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reproduction in any medium, provided the ortheir study had arm pain associated with their neck pain.
The patients with neck and arm pain were more disabled
than patients with only neck pain. Cervico-brachial pain
syndrome is an upper quarter pain syndrome in which
neural tissue sensitivity to mechanical stimulus is thought
to play a role [8,9]. Different terms are often used to
describe patients with upper quadrant pain such as
cervico-brachial pain [10], nerve related neck and arm
pain [11] and cervical radiculopathy [6,12]. Diagnosis of
cervico-brachial pain is made by a clinical process and
there is often no overt neural involvement [8]. Neural
involvement can only be assumed if a cluster of clinical
findings are present such as an active and passive
movement dysfunction, adverse response to neurody-
namic testing and evidence of a local cause of neuro-
pathic pain [8,9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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by a primary lesion or dysfunction in the nervous system
[13]. Neuropathic pain is a problem associated with and
prevalent in many musculoskeletal conditions such as
low back pain [14], acute or chronic radiculopathy [12]
and syndromes such as cervico-brachial pain syndrome
[10,15]. Neuropathic pain is consistently linked to high
levels of pain, disability, poor quality of life and poor re-
sponse to treatment [14,16,17] and is therefore a difficult
condition to treat successfully [14,16].
Psychosocial factors have also been shown to play an
important role in treatment outcomes [18-21]. Pool
et al. [19] examined the influence of different psycho-
social factors on treatment outcome and found fear of
movement to be significantly correlated with poor out-
comes in the short and long term. In a study by Karels
et al. catastrophising was significantly linked to persis-
tent symptoms of neck pain over a six-month period
[22]. Catastrophising is a cognitive process that includes
elements of magnification, helplessness, pessimism and is
a consistently important predictor of poor pain-related
outcomes [23]. Verhagen et al. [20] explored the influence
of various factors on treatment outcome in neck pain and
found pain severity and catastrophising to be the most
important determinants for poor recovery. In a study to
examine factors influencing return to work in patients
with neck/arm/shoulder pain, the authors also concluded
that psychosocial factors should be taken into account
when interventions are planned [18]. Similar to these fin-
dings Thompson et al. [24] found catastrophising and
poor self-efficacy to be associated with higher pain and
disability. Other factors that have been shown to influence
treatment outcomes are pain intensity at baseline, in-
creased age and the presence of low back pain [25,26].
Most clinical guidelines do not differentiate between
treatment for neck pain and neck and arm pain such as
cervico-brachial pain [27]. The American Physical Therapy
Association recommends mobilisation/ manipulation of
the neck and thoracic spine, exercises and education in the
management of neck pain [27]. The findings of a recent
Cochrane review confirm the above recommendations
[28]. The American guidelines [27] also recommend that
neural mobilisation should be considered for patients with
neck and arm pain (level B evidence).
Neural mobilisations (NM) are often used to affect the
neural structures in conditions with signs of neural in-
volvement or neural mechano-sensitivity [10,11]. NM is
said to affect the axoplasmic flow [29], movement of the
nerve and its connective tissue [30], and the circulation
of the nerve by alteration of the pressure in the nervous
system and dispersion of intraneural oedema [31]. NM
can also decrease the excitability of dorsal horn cells
[32]. NM is defined as interventions aimed at affecting
the neural structures or surrounding tissue (interface)directly or indirectly through manual techniques or ex-
ercises. The interface can be mobilised by mobilising the
tissue surrounding the nerve, along the course of the
nerve [33]. Although it is a technique used in clinical
practice the use thereof in the literature could only be
identified in a case report of a patient with cervical radi-
culopathy [34]. The treatment was combined with ma-
nual therapy and exercises, both treatments which have
been shown to be effective for cervical radiculopathy
[28]. It is therefore difficult to know whether the NM
contributed to the treatment effect. The effectiveness of
this form of NM has therefore yet to be established. In
cervico-brachial pain, neural tissue sensitivity to me-
chanical stimulus is thought to play a role [8], it can
therefore be reasoned that targeting the neural struc-
tures specifically should be an important aim of treat-
ment in patients with cervico-brachial pain.
The efficacy of NM has been studied in various popula-
tions such as low back pain [35], carpal tunnel syndrome
[36], lateral epicondalalgia [37] and cervico-brachial pain
[10,11,15]. The NM techniques used for cervico-brachial
pain consisted of cervical lateral glides and neural gliding
exercises [10,15,38]. According to a systematic review of
NM, the evidence for the efficacy of NM is limited [39].
Aims of study
The aims of the study are firstly to establish the effect of
NM on the pain, function and quality of life of patients
with acute and sub-acute cervico-brachial pain. Se-
condly it aims to establish if high catastrophising scores
and neuropathic pain have an influence on treatment
outcomes.
Study design
A randomised controlled trial will be used to answer
the research questions. The study will comprise of two
groups, a control group and an experimental group. The
control group will receive “usual care” (UC) [40] as iden-
tified by a review of the literature. The intervention
group will receive neural mobilisation in addition to the
usual care.
Subjects
Selection procedure
Patients will be recruited from private physiotherapy
practices, which have agreed to take part in the study.
These practices will be situated in the Pretoria region,
Gauteng, South Africa. Patients are referred to pri-
vate practices by general practitioners or may be self-
referred. Patients presenting with cervico-brachial pain
will be screened for eligibility and if eligible will be in-
vited to take part in the study (Figure 1).
To be included in the study patients must be over the
age of 18, with cervico-brachial pain as defined by Hall
Figure 1 Screening and allocation of patients.
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characteristics; antalgic posture, active movement dys-
function, passive movement dysfunction which correlate
with the active movement dysfunction, adverse responses
to neurodynamic tests which must relate specifically
and anatomically to the active and passive movementdysfunction, and mechanical allodynia in response to pal-
pation of specific nerve trunks. Lastly evidence from the
physical examination of a local cause of the neurogenic
pain must be present [8]. The upper limb neurodynamic
test 1 (ULNDT1) will be considered positive if the
patient’s pain is reproduced or partially reproduced by
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Patients with pain from recent onset (one day) up to
12 weeks, recurrent or first incident will be considered for
inclusion. Patients with bilateral arm pain will also be con-
sidered for inclusion if they comply with the other inclu-
sion criteria. Pain due to injury and the duration of pain
will be recorded in the demographics questionnaire that
patients will complete.
Patients who do not have a positive neurodynamic test
will not be included in the study. Patients will be ex-
cluded from the study if they have had previous surgery
or recent fractures of the cervical spine, serious neu-
rological signs such as signs of spinal cord pressure or
involvement of more than two nerve roots, conditions
with long tract signs and those caused by other patho-
logical diseases such as rheumatoid arthritis, neurological
diseases, stroke, cerebral palsy, carcinoma or other red
flags.
Sample size
Primarily this study sets out to assess whether, 6 weeks
after onset of treatment the Numerical Pain Rating Scale
NPRS score in the intervention group is reduced com-
pared to the UC group. A blocked 2:1 ratio randomisa-
tion for intervention to usual care will be done using a
computer generated random number list. A sample size
of 68:34 i.e. a total sample of 102 patients will have 90%
power to detect a clinically relevant increase of 2 for the
change from baseline at six weeks in the NPRS score. A
standard deviation of 2.05 was assumed as derived from
the effect size reported by Bolton and Wilkinson [42].
The standard deviation was furthermore inflated by √2
since change from baseline is of interest. A dropout rate
of 15 – 20% was assumed. One-sided testing will be
done at the 0.05 level of significance. (nQuery advisor 7).
Ethical considerations
Written consent to take part in the study will be
obtained from all study participants and they will receive
an information sheet explaining the study. Written con-
sent will be obtained from treating physiotherapists.
Ethical approval for the study was obtained from the
Human Research Ethics Committee of the University of
the Witwatersrand, Johannesburg, South Africa.
Outcome measures
The treating physiotherapist will administer the first set
of questionnaires. Treatment randomisation will only be
done as described above, after initial measures have been
taken. All subsequent follow up questionnaires will be
administered by a research assistant who will be blinded
to group allocation as the follow up questionnaires at
three weeks and six weeks will be done telephonically.
The primary outcomes are pain (Numeric Pain RatingScale), function (Patient Specific Functional Scale) and
quality of life (EuroQual Instrument). These self-report
outcomes will be followed up at three weeks, six weeks,
six months and 12 months.
The NPRS will be used to measure the patient’s pain.
The NPRS is an 11-point scale where patients are asked to
rate their pain as 0 representing “no pain” and 10 “worst
pain possible”. In a study comparing three pain measures
[42]. Bolton and Wilkinson [42] found the NPRS to be the
most responsive pain measure with an effect size of 0.86
[42]. The validity of the NPRS in an acute setting was
established by Bijur et al. [43] and is strongly correlated
with the visual analogue scale (r = 0.94, 95% Confidence
Interval 0.93 – 0.95) [43]. The NPRS is as sensitive to
change as the visual analogue scale which is currently con-
sidered the “gold standard” [44].
The Patient Specific Functional Scale (PSFS) will be
used to measure disability. The PSFS is a self-report meas-
ure to rate activity limitation and function. Patients are
asked to nominate three to five activities that are difficult
to perform and rate them on an 11 point scale where 0
equals “unable to perform activity” and 10 represents “able
to perform activity as before”. The scale was initially de-
veloped for patients with back pain and validated for pa-
tients with neck pain by Westaway et al. [45]. The scale
has excellent validity (r = 0.73 - 0.83) when compared to
the Neck Disability Index [45]. The test retest reliability
coefficient is excellent (ICC = 0.97) [46]. Cleland et al. [47]
compared the Neck Disability Index (NDI) and the PSFS
in patients with cervical radiculopathy and found that the
PSFS was more responsive than the NDI in this popula-
tion [47]. In their study the test-retest reliability coefficient
was good (ICC 0.82). The scale is commonly used in
physiotherapy practice [48].
EuroQuol Instrument (EQ-5D) is a quality of life
measurement and will be used to rate the quality of life
of study participants. It has two sections: the first part
consists of five sections namely mobility, self-care, usual
activities, pain/discomfort and anxiety/depression. Each
section is rated by three descriptions from “I have no
problem” to “I am unable”. The second section of the
questionnaire has a 20 cm Visual Analogue Scale with
“best imaginable health state” at the one end and “worst
imaginable health state” at the other end. The validity
was established by measuring it against the SF-12 and
positive correlations were found (r = 0.41). It has excel-
lent reliability (ICC 0.82) [49]. Peolsson et al. [50] mea-
sured quality of life using the EQ5D in patients with
cervical radiculopathy and whiplash associated disorder
and found health related quality of life worse in these
populations compared to a healthy group.
Patients will be asked to complete the Global Rating of
Change Scale (GROC) six weeks after treatment has com-
menced. This scale measures the patient’s impression of
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there are eight different scales [51]. In this study an 11
point Likert scale will be used with −5 representing very
much worse, 0 is unchanged and +5 is fully recovered
[51]. The test-retest reliability coefficient is good (ICC of
0.9). The scale correlates significantly with changes on
the Roland Morris, Oswestry, Pain Rating Scale and the
EQ-5D. According to Kamper et al. the Minimal Clinically
Important Change of the GROC is two points on an 11
point scale [51]. Patients with a score of +3 or more will
be considered “responders” and those with a lower score
as “non-responders”.
Two questionnaires will be used to establish which
patients have neuropathic pain and which patients are
catastrophisers. These questionnaires will be repeated at
six months and 12 months to measure if any change has
taken place from initial assessment to one year follow up.
The Neuropathic Pain Diagnostic questionnaire (DN4)
consists of two sections namely an interview and exa-
mination. The interview has two questions, the first
about the characteristics of the pain (e.g. burning) and
the second about associated symptoms (such as pins and
needles) to which the answer is either yes or no. In the
examination, tests for hypoesthesia to touch and prick in
the painful area as well as whether or not brushing ag-
gravates the pain, are done. Each positive scores a point
with a total score of 10. A patient with a score of 4/10
or more can be diagnosed with neuropathic pain [40]. The
sensitivity of the test at the cutoff of four is 82.9 and the
specificity is 89.9. The inter-rater reliability has Kappa
values of between 0.70 and 0.96 [40]. This test have been
used successfully in a South African population that are
not all English first language speakers [52]. The question-
naire is recommended for use in the South African Guide-
lines for management of neuropathic pain [53].
The Pain Catastrophising Scale (PCS) is a ques-
tionnaire that establishes the levels of catastrophising
present in patients. The questionnaire has three compo-
nents: magnification, rumination and helplessness. Par-
ticipants are asked to reflect on past painful experiences
and to indicate the degree to which they experienced
each of 13 thoughts or feelings when experiencing pain.
It is scored on a 5-point scale from 0 “not at all” to 4
“all the time” with a maximum score of 52. A score
above 24 classifies the patient as a catastrophiser [23].
The internal consistency of the three subscales are
Crohnbach’s α of Rumination α = 0.85, Magnification
α = 0.75 and Helplessness α = 0.85 [54]. The reliability as
tested by Osman et al. [54] could correctly identify
77.1% of the cases. Osman et al. [54] also confirm the
findings of Sullivan et al. [23] that the three dimensions
represent a single construct.
The Upper Limb Neurodynamic Test 1 (ULNDT1) is
described as the straight leg raise test of the arm [33].The upper limb nerves are elongated and moved in their
nerve bed [55] as was verified in an in vivo study. The test
consist of different components of movement: patient su-
pine, neck in neutral, shoulder abduction to +/− 110°, ex-
tended wrist and fingers, forearm supination, shoulder
lateral rotation and the amount of elbow extension is then
measured [33]. The reliability of measuring onset of pain
and sub-maximal pain in a clinical setting in patients
with cervico-brachial pain was established as excellent by
Coppieters et al. (ICC ≥ 0.98; SEM ≤ 3.4°) [56]. It is a valid
way of identifying patients with a peripheral neuropathic
pain component [41]. The ULNDT1 will be assessed again
at six months and 12 months.Methods
Pilot study
Four physiotherapists in private practice (including the
researcher) will be the treating physiotherapists. All the
physiotherapists are qualified manual therapists with
knowledge of neural mobilisations. All participating
physiotherapists will take part in a training workshop
run by the researcher. The training workshop will con-
sist of: training of the application of neural mobilisation
along the course of the nerve, protocol for treatment
groups, outcomes measures, baseline measures as well
as patient screening.
The inter- and intra-rater reliability of the researcher and
the research assistant was established for the ULNDT1.
Inter-class correlation coefficient was good at 0.85, (95%
CI 0.66-1.06). Intra-class correlation coefficient for physio-
therapist 1: 0.85, (9 5% CI 0.64 -1.06) and for physiothera-
pist 2: 0.70 (95% CI 0.31- 1.09) which was acceptable.Initial assessment
Patients presenting at participating physiotherapy prac-
tices with neck and arm pain will be screened for inclu-
sion into the study. Suitable candidates will receive a full
musculoskeletal examination to confirm that they comply
with the criteria for cervico-brachial pain as described
above [8]. They will then complete the questionnaires as
discussed.
Physical examination will include the ULNDT1. The test
will be done as described above [33]. The range of
ULNDT1 will be measured using a standard goniometer
to measure the range of elbow extension [57]. The exami-
nation section of the DN4, that is; testing for hypoesthesia
to touch, and prick and pain caused by brushing will be
done at baseline, six months and 12 months. Neural con-
duction tests of sensation, muscle power and reflexes will
be done according to Petty & Moore [58] at six and
12 months. They will also be asked to complete a demo-
graphic questionnaire on age, gender, duration of symp-
toms, previous neck pain, injury or insidious onset,
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ziness and indicate the area of pain on a body chart.
Randomisation
Block Randomisation with a 2:1 ratio in blocks of 6 will be
done [59,60]. According to Moher et al. [61] an unequal
randomisation is ideal for smaller randomised controlled
trials and multicentre trials [61]. Randomisation will be
done using a computer random generator [62]. An inde-
pendent research assistant, naïve to study content, will be
contacted by telephone. This research assistant will give a
patient number sequentially and treatment (group) alloca-
tion to participating physiotherapists after all baseline
measurements has been done.
Physiotherapists will receive an envelope with the
patient information leaflet, consent form, treatment re-
cording sheet and all questionnaires. Group allocation
will not be visible and the research assistant doing follow
up measurements will be blinded to group allocation.
Treatment recording sheets will only be collected at the
end of the data collection period. The treatment sheets
will be used to assess whether treatment allocation was
followed, number of treatment sessions and to screen
for any adverse events due to treatment.
Intervention
The American Physical Therapy Association Guidelines
[27] as well as the Australian Guidelines [63] both rec-
ommend the use of a multimodal intervention com-
prising of gentle exercise, advice to stay active and
cervical mobilisation/manipulation. The usual care (UC)
[40] will be given according to these guidelines to ensure
that all patients receive evidence based care. No specific
mobilisation/ manipulation technique have been shown
to be superior to another [64,28].
The UC will consist of mobilisation of the cervical and
thoracic spine, exercises and advice to stay active. As most
physiotherapists in South Africa have been Maitland
trained, the patients will receive Maitland mobilisation
[65] of the cervical and thoracic spine. Exercises will
include postural correction, deep neck flexor training
according to Falla et al. [66] and strengthening and mobi-
lising exercises using yellow Theraband™ as described by
[67]. All study participants will receive advice to stay ac-
tive [27]. The number of treatments will range between
two and a maximum of eight treatments and will be re-
corded. Patients who have not improved by the sixth treat-
ment or patients who report any adverse events will be
referred back to their general practitioners. Patients in the
UC group will not receive any neural mobilisations.
The intervention group will receive the NM in
addition to UC. The NM used in this study will be done
as described by Butler [33], a gentle soft tissue mobilisa-
tion of the neural container/interface “along the tract”([33] pp. 380) of the nerve – directly where the nerve is
palpable and indirectly where it lies deeper. The treat-
ment will concentrate on areas where the nerve is
mechano-sensitive to palpation and will be done from
the hand or elbow (depending on patient’s area of pain)
and followed up along the arm, first rib, scalene and into
the neck. Mobilisation will first be done in a position
where the nerve is relaxed, not provoking any of the pa-
tient’s symptoms. Palpation may only provoke minimal
symptoms and should disappear as soon as it is stopped.
The basic principles of neural mobilisations will be used
to progress treatment; that is to commence treatment in
the acute phase with the nerve in a neutral, non-tension
position and to progress into a more tensioned position
as pain and irritability improves [33,68].
Statistical considerations
Primarily this study sets out to assess whether, six weeks
after onset of treatment the NPRS score in the interven-
tion group is reduced compared to the UC group. The
sample size calculation is reported for the NPRS, which
require the largest sample size.
Data analysis
The data summary will employ descriptive statistics, means,
standard deviations and 95% confidence intervals and will
be reported by study group (intervention & standard care)
for the NPRS, PSFS and EQ-5D. Catastrophising (yes & no)
and neuropathic pain (yes & no) will be summarised using
frequencies, percentages, cross tables and 95% confidence
intervals.
Two treatment groups will be compared with respect
to the change from baseline at six weeks in the NPRS,
PSFS and EQ-5D scores using an analysis of covariance
(ANCOVA) with baseline scores, catastrophising (yes &
no) and neuropathic pain (yes & no) as covariates. For
the total assessment period of 12 months the interaction
between visits and treatment will be assessed with
respect to NPRS, PSFS and EQ-5D scores in a linear
mixed model analysis. Testing will be done at the 0.05
level of significance. For all data description and analyses
an intention-to-treat analysis will be performed.
Discussion
Evidence for the treatment of neck and arm pain (inclu-
ding radiculopathy) is sparse [28]. In a recent review of
non-invasive treatment for cervico-brachial pain, Salt
et al. [6] found inconclusive evidence for the effectiveness
of treatment on pain. Potential benefit was found for ma-
nual therapy, exercise and behavioural change approaches.
The effect of treatment on function in this population
group was mixed. They recommend that studies investi-
gate which subgroups of patients will respond to specific
interventions. It is postulated that mechano sensitivity of
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study the effect of neural mobilisation on a population
with cervico-brachial pain and nerve mechano-sensitivity
will be investigated. Clinical reasoning suggests that tar-
geting the neural structures in these patients could be
beneficial.
Conclusion
The findings of this study should add to the knowledge
base on the management of patients with cervico-
brachial pain. Results of this study will be published in
an appropriate journal.
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